Cargando…
Colistin resistance screening by 3 μg/ml colistin agar in Carbapenemase‐producing Enterobacterales
BACKGROUND: In low‐ and middle‐income countries, the use of colistin in therapeutic regimens is common, to treat infections produced for Carbapenemase‐producing Enterobacterales (CPE) due to limited access to the recently discovered‐approved antibiotics. Furthermore, the technical limitations to per...
Autores principales: | Soria‐Segarra, Claudia, Soria‐Segarra, Carmen, Andrade‐Soriano, Michelle, Quezada, Tamara Nuñez, Gestal, Monica C., Gutierrez‐Fernandez, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459281/ https://www.ncbi.nlm.nih.gov/pubmed/35944176 http://dx.doi.org/10.1002/jcla.24639 |
Ejemplares similares
-
Risk factors associated with colistin resistance in carbapenemase-producing Enterobacterales: a multicenter study from a low-income country
por: Claudia, Soria-Segarra, et al.
Publicado: (2023) -
Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant Enterobacterales
por: Liu, Yi-Yun, et al.
Publicado: (2022) -
Prevalence and zoonotic transmission of colistin-resistant and carbapenemase-producing Enterobacterales on German pig farms
por: Effelsberg, Natalie, et al.
Publicado: (2021) -
Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin
por: Turlej-Rogacka, Agata, et al.
Publicado: (2017) -
Utility of CHROMagar mSuperCARBA for surveillance cultures of carbapenemase-producing Enterobacteriaceae
por: Soria Segarra, Cl., et al.
Publicado: (2018)